These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 12869834)

  • 41. Quantitative analysis of human mitochondrial DNA using a real-time PCR assay.
    Gourlain K; Amellal B; Ait Arkoub Z; Dupin N; Katlama C; Calvez V
    HIV Med; 2003 Jul; 4(3):287-92. PubMed ID: 12859329
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Mitochondrial alterations with mitochondrial DNA depletion in the nerves of AIDS patients with peripheral neuropathy induced by 2'3'-dideoxycytidine (ddC).
    Dalakas MC; Semino-Mora C; Leon-Monzon M
    Lab Invest; 2001 Nov; 81(11):1537-44. PubMed ID: 11706061
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Hyperlactataemia in HIV-infected subjects initiating antiretroviral therapy in a large randomized study (a substudy of the INITIO trial).
    Feeney ER; Chazallon C; O'Brien N; Meiffrédy V; Goodall RL; Aboulker JP; Cooper DA; Yeni P; Mallon PW;
    HIV Med; 2011 Nov; 12(10):602-9. PubMed ID: 21599820
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A randomized, double-blind study of triple nucleoside therapy of abacavir, lamivudine, and zidovudine versus lamivudine and zidovudine in previously treated human immunodeficiency virus type 1-infected children. The CNAA3006 Study Team.
    Sáez-Llorens X; Nelson RP; Emmanuel P; Wiznia A; Mitchell C; Church JA; Sleasman J; Van Dyke R; Richardson CG; Cutrell A; Spreen W; Hetherington S
    Pediatrics; 2001 Jan; 107(1):E4. PubMed ID: 11134468
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effects of the change from Stavudine to tenofovir in human immunodeficiency virus-infected children treated with highly active antiretroviral therapy: studies on mitochondrial toxicity and thymic function.
    Rosso R; Nasi M; Di Biagio A; Repetto E; Dentone C; Pinti M; Nemes E; Ferraresi R; Mussini C; Esposito R; Viscoli C; Cossarizza A
    Pediatr Infect Dis J; 2008 Jan; 27(1):17-21. PubMed ID: 18162932
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Nucleoside reverse transcriptase inhibitors, mitochondrial DNA and AIDS therapy.
    Lewis W
    Antivir Ther; 2005; 10 Suppl 2():M13-27. PubMed ID: 16152703
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Prospective evaluation of blood concentration of mitochondrial DNA as a marker of toxicity in 157 consecutively recruited untreated or HAART-treated HIV-positive patients.
    Chiappini F; Teicher E; Saffroy R; Pham P; Falissard B; Barrier A; Chevalier S; Debuire B; Vittecoq D; Lemoine A
    Lab Invest; 2004 Jul; 84(7):908-14. PubMed ID: 15122308
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Reductions in viral load and increases in T lymphocyte numbers in treatment-naive patients with advanced HIV-1 infection treated with ritonavir, zidovudine and zalcitabine triple therapy.
    Mathez D; Bagnarelli P; Gorin I; Katlama C; Pialoux G; Saimot G; Tubiana P; De Truchis P; Chauvin JP; Mills R; Rode R; Clementi M; Leibowitch J
    Antivir Ther; 1997 Jul; 2(3):175-83. PubMed ID: 11322272
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Mitochondrial (mt)DNA changes in tissue may not be reflected by depletion of mtDNA in peripheral blood mononuclear cells in HIV-infected patients.
    Maagaard A; Holberg-Petersen M; Kollberg G; Oldfors A; Sandvik L; Bruun JN
    Antivir Ther; 2006; 11(5):601-8. PubMed ID: 16964828
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Mitochondrial DNA levels of peripheral blood mononuclear cells and subcutaneous adipose tissue from thigh, fat and abdomen of HIV-1 seropositive and negative individuals.
    Gerschenson M; Shiramizu B; LiButti DE; Shikuma CM
    Antivir Ther; 2005; 10 Suppl 2():M83-9. PubMed ID: 16152709
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Mitochondrial assessment in asymptomatic HIV-infected paediatric patients on HAART.
    Morén C; Noguera-Julian A; Rovira N; Garrabou G; Nicolàs M; Cardellach F; Martínez E; Sánchez E; Miró O; Fortuny C
    Antivir Ther; 2011; 16(5):719-24. PubMed ID: 21817193
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Mitochondrial changes during D-drug-containing once-daily therapy in HIV-positive treatment-naive patients.
    Maggiolo F; Roat E; Pinti M; Nasi M; Gibellini L; De Biasi S; Airoldi M; Ravasio V; Mussini C; Suter F; Cossarizza A
    Antivir Ther; 2010; 15(1):51-9. PubMed ID: 20167991
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Infection with HIV-1 induces a decrease in mtDNA.
    Casula M; Bosboom-Dobbelaer I; Smolders K; Otto S; Bakker M; de Baar MP; Reiss P; de Ronde A
    J Infect Dis; 2005 May; 191(9):1468-71. PubMed ID: 15809905
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Exploring mitochondrial nephrotoxicity as a potential mechanism of kidney dysfunction among HIV-infected patients on highly active antiretroviral therapy.
    Côté HC; Magil AB; Harris M; Scarth BJ; Gadawski I; Wang N; Yu E; Yip B; Zalunardo N; Werb R; Hogg R; Harrigan PR; Montaner JS
    Antivir Ther; 2006; 11(1):79-86. PubMed ID: 16518963
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Mitochondrial effects of a 24-week course of pegylated-interferon plus ribavirin in asymptomatic HCV/HIV co-infected patients on long-term treatment with didanosine, stavudine or both.
    Ballesteros AL; Miró O; López S; Fuster D; Videla S; Martínez E; Garrabou G; Salas A; Côté H; Tor J; Rey-Joly C; Planas R; Clotet B; Tural C
    Antivir Ther; 2004 Dec; 9(6):969-77. PubMed ID: 15651755
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Changes in body composition and mitochondrial nucleic acid content in patients switched from failed nucleoside analogue therapy to ritonavir-boosted indinavir and efavirenz.
    Boyd MA; Carr A; Ruxrungtham K; Srasuebkul P; Bien D; Law M; Wangsuphachart S; Krisanachinda A; Lerdlum S; Lange JM; Phanuphak P; Cooper DA; Reiss P
    J Infect Dis; 2006 Sep; 194(5):642-50. PubMed ID: 16897663
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Uridine abrogates mitochondrial toxicity related to nucleoside analogue reverse transcriptase inhibitors in HepG2 cells.
    Walker UA; Venhoff N; Koch EC; Olschewski M; Schneider J; Setzer B
    Antivir Ther; 2003 Oct; 8(5):463-70. PubMed ID: 14640394
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Mitochondrial DNA depletion in HIV-infected patients with chronic hepatitis C and effect of pegylated interferon plus ribavirin therapy.
    de Mendoza C; Martin-Carbonero L; Barreiro P; de Baar M; Zahonero N; Rodriguez-Novoa S; Benito JM; González-Lahoz J; Soriano V
    AIDS; 2007 Mar; 21(5):583-8. PubMed ID: 17314520
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Gene expression and immunohistochemistry in adipose tissue of HIV type 1-infected patients with nucleoside analogue reverse-transcriptase inhibitor-associated lipoatrophy.
    Sievers M; Walker UA; Sevastianova K; Setzer B; Wågsäter D; Eriksson P; Yki-Järvinen H; Sutinen J
    J Infect Dis; 2009 Jul; 200(2):252-62. PubMed ID: 19519254
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Mutations in HIV-1 reverse transcriptase during therapy with abacavir, lamivudine and zidovudine in HIV-1-infected adults with no prior antiretroviral therapy.
    Ait-Khaled M; Rakik A; Griffin P; Cutrell A; Fischl MA; Clumeck N; Greenberg SB; Rubio R; Peters BS; Pulido F; Gould J; Pearce G; Spreen W; Tisdale M; Lafon S;
    Antivir Ther; 2002 Mar; 7(1):43-51. PubMed ID: 12008787
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.